Title: Clinical Performance and Outcomes After Sphere Lens Transition
Clinical Performance and Patient Outcomes When Transitioning From Comfilcon A Sphere to Fanfilcon A Sphere Lenses.
To evaluate subjective and clinical outcomes after transitioning from one sphere soft contact lens to another over a one-month period.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Jose Vega, O.D., MSc., PhD, FAAO
- Phone Number: 9256402964
- Email: JVega2@coopervision.com
Study Contact Backup
- Name: Komalpreet Kaur, BS
- Phone Number: 9256604439
- Email: KoKaur@coopervision.com
Study Locations
-
-
State of Mexico
-
México, State of Mexico, Mexico, CP 06760
- Consultorio Optométrico
-
Contact:
- Dr. Ruben Velazquez Guerrero, OD
- Phone Number: +525528991976
- Email: rubenvg@unam.mx
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Participants with eyes appropriate for the study being conducted
- They are at least 18 years of age.
- They understand their rights as a research participant and are willing and able to sign a Statement of Informed Consent.
- Current habitual wearer of Biofinity soft sphere contact lenses with contact lens power ranging from +8.00 to -12.00 DS.
- Anisometropia no greater than 1.50D, based on contact lens power spherical equivalent.
- Can achieve visual acuity of at least 0.1 logMAR (20/25) in each eye with contact lenses.
- Able to wear the study contact lenses for 6 days a week, minimum 8 hours a day.
- Can be fitted with the study contact lenses (Avaira Vitality® sphere).
- They agree not to participate in any other clinical research study while enrolled in this study.
Exclusion Criteria:
- 1. Anterior segment infection, inflammation or abnormality 2. Any active anterior segment ocular disease that would contraindicate contact lens wear 3. The use of systemic or ocular medications that would contraindicate contact lens wear 4. History of herpetic keratitis 5. History of refractive surgery or irregular cornea 6. Slit lamp findings that are more serious than grade 1 (ISO scale). 7. Inactive (i.e. ghost) vessels greater than 1 mm of penetration into the cornea 8. They have corneal distortion resulting from previous hard or rigid lens wear or have keratoconus.
9. They have participated in a contact lens or contact lens care product clinical trial in the past 30 days
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Refit to Fanfilcon A Sphere Contact Lens
Habitual wears of Confilcon A soft sphere contact lenses Refitted to Fanfilcon A sphere contact lense s and followed for one month. |
Participants are refit from their habitual sphere soft contact lenses to fanfilcon A sphere contact lenses and wear the lenses for approximately one month according to the study protocol. |
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Subjective Comfort
Time Frame: Baseline, 1 week, and 1 month.
|
Subjective comfort on insertion (0-100 Visual analogue scale) |
Baseline, 1 week, and 1 month.
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- MKTG-26-40
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.